IP Library Patent Application 17023097
Patent Application
App. No. 17/023,097

SPORE-BASED PROBIOTIC SUPPLEMENTATION IN DOGS AND CONTROL OF ENDOTOXEMIA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/023,097
Abstract

The present invention is directed to methods of administering a probiotic composition including Bacillus subtilis, Bacillus licheniformis , and Pediococcus acidilactici to dogs to decrease endotoxemia and improve the digestive process, and related methods.

Claims (31)

1 . A method of decreasing endotoxemia in a dog comprising the steps of:

a. providing a probiotic composition comprising Bacillus subtilis, Bacillus licheniformis , and Pediococcus acidilactici , and

b. administering the probiotic composition to the dog in an amount effective to decrease endotoxemia in the dog.

2 . The method of claim 1 , wherein said Bacillus subtilis is Bacillus subtilis HU58 and/or said Bacillus licheniformis is Bacillus licheniformis SL-307.

3 . The method of claim 1 , wherein said Bacillus subtilis, Bacillus licheniformis , and Pediococcus acidilactici total about 1 billion to about 10 billion CFU.

4 . The method of claim 3 , wherein said CFU total is about 2.5 billion to about 5 billion CFU.

5 . The method of claim 3 , wherein said CFU total is about 2 billion CFUs Bacillus subtilis HU58, about 500 million to 1 billion CFUs Pediococcus acidilactici , and about 100 million CFUs of Bacillus licheniformis.

6 . The method of claim 1 , wherein said probiotic composition is orally administered to the dog.

7 . The method of claim 4 , wherein said oral administration is for at least 30 days.

8 . The method of claim 1 , wherein said dog is a healthy dog.

9 . The method of claim 1 , wherein said dog has a disorder of the gastrointestinal tract.

10 . A method of improving digestion in the gastrointestinal tract of a dog comprising the steps of:

a. providing a probiotic composition comprising Bacillus subtilis, Bacillus licheniformis , and Pediococcus acidilactici , and

b. administering the probiotic composition to the dog in an amount effective to improve the digestive process in gastrointestinal tract of the dog.

11 . The method of claim 10 , wherein said Bacillus subtilis is Bacillus subtilis HU58 and/or said Bacillus licheniformis is Bacillus licheniformis SL-307.

12 . The method of claim 10 , wherein said Bacillus subtilis, Bacillus licheniformis , and Pediococcus acidilactici total about 1 billion to about 10 billion CFU.

13 . The method of claim 12 , wherein said CFU total is about 2.5 billion to about 5 billion CFU.

14 . The method of claim 12 , wherein said CFU total is about 2 billion CFUs Bacillus subtilis HU58, about 500 million to 1 billion CFUs Pediococcus acidilactici , and about 100 million CFUs of Bacillus licheniformis.

15 . The method of claim 12 , wherein said probiotic composition is orally administered to the dog.

16 . The method of claim 15 , wherein said oral administration is for at least 30 days.

17 . The method of claim 1 , wherein said dog is a healthy dog.

18 . The method of claim 1 , wherein said dog has a disorder of the gastrointestinal tract.

19 . A method of treating a digestive disorder in a dog comprising the steps of:

a. providing a probiotic composition comprising Bacillus subtilis, Bacillus licheniformis , and Pediococcus acidilactici , and

b. administering the probiotic composition to the dog in an amount effective to decrease or eliminate a digestive disorder symptom in the dog.

20 . The method of claim 19 , wherein said Bacillus subtilis is Bacillus subtilis HU58 and/or said Bacillus licheniformis is Bacillus licheniformis SL-307.

21 . The method of claim 19 , wherein said Bacillus subtilis, Bacillus licheniformis , and Pediococcus acidilactici total about 1 billion to about 10 billion CFU.

22 . The method of claim 21 , wherein said CFU total is about 2.5 billion to about 5 billion CFU.

23 . The method of claim 21 , wherein said CFU total is about 2 billion CFUs Bacillus subtilis HU58, about 500 million to 1 billion CFUs Pediococcus acidilactici , and about 100 million CFUs of Bacillus licheniformis.

24 . The method of claim 19 , wherein said probiotic composition is orally administered to the dog.

25 . The method of claim 22 , wherein said oral administration is for at least 30 days.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2022
From: MICROBIOME LABS, LLC
To: NOVOZYMES A/S
Reel/Frame 059066/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2021
From: BAYNE, THOMAS F.; KRIZ, DALE M.; KRISHNAN, KIRAN
To: MICROBIOME LABS, LLC
Reel/Frame 057583/0373 →